PI
-
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial
Mocking, T. R., Haaksma, L. H., Reuvekamp, T., Kelder, A., Scholten, W. J., Ngai, L. L., Breems, D. A., Fischer, T., Gjertsen, B. T., Griškevičius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R., Porkka, K., Valk, P. J. M., Gradowska, P., Löwenberg, B. & de Leeuw, D. C. & 5 others, , Oct 2025, In: Leukemia. 39, 10, p. 2559-2562 4 p.Research output: Contribution to journal › Article › Academic › peer-review
-
A revised prognostic model for patients with acute myeloid leukemia and first relapse
van der Maas, N. G., Breems, D., Klerk, C. P. W., Pabst, T., Gradowska, P., Thomas, A., Biemond, B. J., Kuball, J., van Elssen, C. H. M. J., Visser, O., Vekemans, M.-C., Graux, C., Maertens, J., Knapper, S., Dennis, M., Freeman, S., Thomas, I., Berna Beverloo, H., Huls, G. & Craddock, C. & 7 others, , 12 Aug 2025, In: Blood. 9, 15, p. 3853-3864Research output: Contribution to journal › Article › Academic › peer-review
-
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapy
van der Schans, J. J., Vishwasrao, P., Poels, R., Antti, M., Wang, Z., Quik, M., van Arkel, J., Reuvekamp, T., van de Donk, N. W. C. J., Themeli, M., Ossenkoppele, G. J., van de Loosdrecht, A. A., Richards, R. & Mutis, T., 1 Jul 2025, In: HemaSphere. 9, 7, e70155.Research output: Contribution to journal › Article › Academic › peer-review
- All publications